Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

NCT04662684 is registered in ClinicalTrials.gov with Science Valley Research Institute as lead sponsor.

NCT NCT04662684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial
Lead sponsor
Science Valley Research Institute
Phase
Phase 3
Overall status
Completed
Start date
October 16, 2020
Completion date
August 30, 2021
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, venous thromboembolism